Cargando…
Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty
BACKGROUD: Intravenous tranexamic acid (TXA) has been shown to reduce blood loss in patients undergoing total joint arthroplasty without systemic complications. There is limited evidence of its effectiveness in revision procedures. This study evaluated intravenous TXA effect on blood loss, transfusi...
Autores principales: | Gianakos, Arianna L., Saad, Bishoy N., Haring, Richard, Menken, Luke G., Elkattaway, Sherif, Liporace, Frank A., Yoon, Richard S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111901/ https://www.ncbi.nlm.nih.gov/pubmed/33975621 http://dx.doi.org/10.1186/s13037-021-00295-5 |
Ejemplares similares
-
Correction to: Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty
por: Gianakos, Arianna L., et al.
Publicado: (2022) -
Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients
por: Buzin, Scott, et al.
Publicado: (2020) -
Tranexamic acid is associated with decreased transfusion, hospital length of stay, and hospital cost in simultaneous bilateral total knee arthroplasty
por: D’Souza, Ryan S., et al.
Publicado: (2021) -
Perioperative intravenous tranexamic acid reduces blood transfusion in primary cementless total hip arthroplasty
por: Andrea, Sandri, et al.
Publicado: (2019) -
Hospital variation in allogeneic transfusion and extended length of stay in primary elective hip and knee arthroplasty: a cross-sectional study
por: Voorn, Veronique M A, et al.
Publicado: (2017)